BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rock EM, Sullivan MT, Collins SA, Goodman H, Limebeer CL, Mechoulam R, Parker LA. Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews. Psychopharmacology (Berl) 2020;237:2621-31. [PMID: 32488349 DOI: 10.1007/s00213-020-05559-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Rock EM, Limebeer CL, Smoum R, Mechoulam R, Parker LA. Evaluation of Sex Differences in the Potential of Δ9-Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats. Cannabis Cannabinoid Res 2022. [PMID: 35984924 DOI: 10.1089/can.2022.0158] [Reference Citation Analysis]
2 Sionov RV, Steinberg D. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. Biomedicines 2022;10:631. [DOI: 10.3390/biomedicines10030631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Attard TM, Goodwin C, Nalivaika P, Attard J, Budarin VL, Lanot A, Bove D, Clark JH, Mcelroy CR. Simple, quick and green isolation of cannabinoids from complex natural product extracts using sustainable mesoporous materials (Starbon®). Mater Chem Front . [DOI: 10.1039/d2qm00028h] [Reference Citation Analysis]
4 Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Front Pharmacol 2021;12:777804. [PMID: 34916950 DOI: 10.3389/fphar.2021.777804] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Ward SJ, Lichtman AH, Piomelli D, Parker LA. Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects. J Natl Cancer Inst Monogr 2021;2021:78-85. [PMID: 34850893 DOI: 10.1093/jncimonographs/lgab007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Reyes-Cuapio E, Coronado-Álvarez A, Quiroga C, Alcaraz-Silva J, Ruíz-Ruíz JC, Imperatori C, Murillo-Rodríguez E. Juvenile cannabidiol chronic treatments produce robust changes in metabolic markers in adult male Wistar rats. Eur J Pharmacol 2021;910:174463. [PMID: 34478689 DOI: 10.1016/j.ejphar.2021.174463] [Reference Citation Analysis]
7 Filipiuc LE, Ababei DC, Alexa-Stratulat T, Pricope CV, Bild V, Stefanescu R, Stanciu GD, Tamba BI. Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? Pharmaceutics 2021;13:1823. [PMID: 34834237 DOI: 10.3390/pharmaceutics13111823] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
8 Rock EM, Limebeer CL, Smoum R, Mechoulam R, Parker LA. Effect of oleoyl glycine and oleoyl alanine on lithium chloride induced nausea in rats and vomiting in shrews. Psychopharmacology (Berl) 2021. [PMID: 34676441 DOI: 10.1007/s00213-021-06005-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Mnekin L, Ripoll L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics 2021;8:85. [DOI: 10.3390/cosmetics8030085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Ikarashi N, Shiseki M, Yoshida R, Tabata K, Kimura R, Watanabe T, Kon R, Sakai H, Kamei J. Cannabidiol Application Increases Cutaneous Aquaporin-3 and Exerts a Skin Moisturizing Effect. Pharmaceuticals (Basel) 2021;14:879. [PMID: 34577578 DOI: 10.3390/ph14090879] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Rock EM, Limebeer CL, Pertwee RG, Mechoulam R, Parker LA. Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting. Cannabis Cannabinoid Res 2021;6:266-74. [PMID: 34115951 DOI: 10.1089/can.2021.0041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Navarrete C, García-Martín A, Rolland A, DeMesa J, Muñoz E. Cannabidiol and Other Cannabinoids in Demyelinating Diseases. Int J Mol Sci 2021;22:2992. [PMID: 33804243 DOI: 10.3390/ijms22062992] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Malinowska B, Baranowska-Kuczko M, Kicman A, Schlicker E. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19. Int J Mol Sci 2021;22:1986. [PMID: 33671463 DOI: 10.3390/ijms22041986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]